New ultrasensitive detection technologies and techniques for use in microdosing studies

被引：22

作者：

Lappin, Graham ^{[1
]}

Wagner, Claudia C. ^{[1
]}

Langer, Oliver ^{[1
,2
]}

van de Merbel, Nico ^{[3
]}

机构：

[1] Xceleron Inc, Germantown, MD USA

[2] Austrian Res Ctr GmbH ARC, Dept Radiopharmaceut & MicroPET Imaging, Seibersdorf, Austria

[3] PRA Int Early Dev Serv, Bioanalyt Lab, NL-9405 BJ Assen, Netherlands

来源：

BIOANALYSIS | 2009年 / 1卷 / 02期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; MASS-SPECTROMETRY; PHARMACOKINETIC EVALUATION; DRUG DEVELOPMENT; RATS; PET; METABOLISM; DISCOVERY;

D O I：

10.4155/BIO.09.40

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at an early stage of development in order to obtain preliminary pharmacokinetic data. The very low doses of drug administered (<= 100 mu g) consequently lead to very low concentrations of drug appearing in the body and therefore highly sensitive analytical techniques are required. There are three such analytical technologies currently used in microdosing studies: PET, liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and accelerator mass spectrometry (AMS). Both PET and AMS employ radioisotopic tracers. PET is an imaging technique and AMS is an extremely sensitive isotope ratio method, able to measure drug concentrations in the ag/ml range. LC-MS/MS does not require the presence of an isotopic tracer and its sensitivity is in the pg/ml range. This review examines each of these three analytical modalities in the context of performing microdosing studies.

引用

页码：357 / 366

页数：10

共 56 条

[1]

Aboagye EO, 2001, CANCER RES, V61, P4937

[2]

Audus K.L., 1992, ADV DRUG RES, V23, P1

[3] F-18-labeling and biodistribution of the novel fluoro-quinolone antimicrobial agent, trovafloxacin (CP 99,219) [J].